Thulium laser vaporesection of the prostate: Can we operate without interrupting oral antiplatelet/anticoagulant therapy?


Sener T. E. , Buttice S., Macchione L., Netsch C., TANIDIR Y. , Dragos L., ...More

INVESTIGATIVE AND CLINICAL UROLOGY, vol.58, no.3, pp.192-199, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 58 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.4111/icu.2017.58.3.192
  • Title of Journal : INVESTIGATIVE AND CLINICAL UROLOGY
  • Page Numbers: pp.192-199

Abstract

Purpose: Thulium vaporesection of the prostate (ThuVARP) is a new and safe approach for patients receiving anticoagulant therapy in whom transurethral resection of the prostate (TURP) may possess a high bleeding risk. We aimed to demonstrate the efficacy and safety of ThuVARP in patients receiving oral antiplatelet/anticoagulant (OAP/OAC) therapy.